Literature DB >> 1916229

Analysis of the human serological response to Chlamydia trachomatis 60-kDa proteins by two-dimensional electrophoresis and immunoblotting.

A M Coles1, H A Crosby, J H Pearce.   

Abstract

Earlier analyses of sera from humans and animals with chlamydial infections demonstrated a strong immune response to proteins of approximately 60 kDa. We have used two-dimensional (2D) electrophoresis followed by immunoblotting to more accurately define patient responses to the chlamydial 60-kDa cysteine-rich envelope protein (OMP2) and to the 57-kDa stress protein (SP) implicated in immunopathological damage. OMP2 and SP were separated on 2D gels by their distinct isoelectric points and identified by fluorography of [35S]-labelled proteins and cross-reaction with anti-mycobacterial antiserum, respectively. The majority of patients sera showed a strong reaction both to OMP2 and the SP (18/20 and 17/20 sera, respectively). Fewer sera (9/20 and 10/20 sera, respectively) reacted with two other polypeptides also present in the 60-kDa range by this analysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916229     DOI: 10.1016/0378-1097(91)90231-x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis.

Authors:  H Enroth; T Akerlund; A Sillén; L Engstrand
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.

Authors:  J C Goodall; H Beacock-Sharp; K H Deane; J S Gaston
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge.

Authors:  S Pal; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Use of monoclonal antibodies to facilitate identification, cloning, and purification of Chlamydia trachomatis hsp10.

Authors:  D LaVerda; G I Byrne
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones.

Authors:  A B Hassell; D J Reynolds; M Deacon; J S Gaston; J H Pearce
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

7.  Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.